Eur Heart J. 2000 Sep;21(18):1502-13. doi: 10.1053/euhj.2000.2305.
This document was developed by a consensus conference initiated by Kristian Thygesen, MD, and Joseph S. Alpert, MD, after formal approval by Lars Rydén, MD, President of the European Society of Cardiology (ESC), and Arthur Garson, MD, President of the American College of Cardiology (ACC). All of the participants were selected for their expertise in the field they represented, with approximately one-half of the participants selected from each organization. Participants were instructed to review the scientific evidence in their area of expertise and to attend the consensus conference with prepared remarks. The first draft of the document was prepared during the consensus conference itself. Sources of funding appear in Appendix A. The recommendations made in this document represent the attitudes and opinions of the participants at the time of the conference, and these recommendations were revised subsequently. The conclusions reached will undoubtedly need to be revised as new scientific evidence becomes available. This document has been reviewed by members of the ESC Committee for Scientific and Clinical Initiatives and by members of the Board of the ESC who approved the document on April 15, 2000.*
本文件由医学博士克里斯蒂安·蒂格森(Kristian Thygesen)和医学博士约瑟夫·S·阿尔珀特(Joseph S. Alpert)发起的共识会议制定,此前得到了欧洲心脏病学会(ESC)主席医学博士拉尔斯·里登(Lars Rydén)和美国心脏病学会(ACC)主席医学博士亚瑟·加森(Arthur Garson)的正式批准。所有参与者均因其在所代表领域的专业知识而被挑选,每个组织大约挑选了一半的参与者。参与者被要求审查其专业领域的科学证据,并带着准备好的发言参加共识会议。文件的初稿是在共识会议期间起草的。资金来源见附录A。本文件中的建议代表了会议期间参与者的态度和意见,这些建议随后进行了修订。随着新科学证据的出现,得出的结论无疑需要修订。本文件已由ESC科学与临床倡议委员会成员以及ESC董事会成员进行了审查,他们于2000年4月15日批准了该文件。*